Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cutera Inc (NQ: CUTR )

41.11 +0.73 (+1.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 802,239
Open 40.58
Bid (Size) 16.78 (1)
Ask (Size) 45.27 (1)
Prev. Close 40.38
Today's Range 39.72 - 42.62
52wk Range 31.62 - 74.38
Shares Outstanding 17,942,446
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
New Research Reveals Roughly 4 in 5 Moderate to Severe Acne Sufferers Have Missed Moments in Their Life Due to Acne
From Cutera, Inc.
Via Business Wire
Cutera's Return On Capital Employed Insights
Cutera (NASDAQ:CUTR) brought in sales totaling $58.01 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 284.8%, resulting in a loss of $15.14 million. 
Via Benzinga

Performance

YTD
+3.08%
+3.08%
1 Month
-8.30%
-8.30%
3 Month
-32.52%
-32.52%
6 Month
+4.55%
+4.55%
1 Year
-13.96%
-13.96%

More News

Read More
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
Via Benzinga
Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes
From Cutera, Inc.
Via Business Wire
Why Cutera's Shares Are Soaring Today
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
Cutera, Inc. Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
From Cutera, Inc.
Via Business Wire
Recap: Cutera Q1 Earnings
Via Benzinga
Cutera Announces Record First Quarter 2022 Revenue Results
From Cutera, Inc.
Via Business Wire
Cutera’s AviClear™ Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)
From Cutera, Inc.
Via Business Wire
Cutera, Inc. to Announce First Quarter Results on May 10, 2022
From Cutera, Inc.
Via Business Wire
Cutera Partners with Synchrony to Provide Financing Options to Dermatology Patients for Innovative New Acne Treatment
From Cutera, Inc.
Via Business Wire
Cutera Announces First Patient Treated with FDA Cleared AviClear™ Acne Device
From Cutera, Inc.
Via Business Wire
Cutera Clears Stock Hits Key Benchmark, Hitting 90-Plus RS Rating
Via Investor's Business Daily
Mid-Afternoon Market Update: Dow Falls 30 Points; Cutera Shares Spike Higher
Via Benzinga
64 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
FDA Clears Cutera’s AviClear™ Acne Device
From Cutera, Inc.
Via Business Wire
Cutera, Inc. to Participate in the Aesthetic Device Industry Panel at the Maxim Virtual Growth Conference
From Cutera, Inc.
Via Business Wire
Recap: Cutera Q4 Earnings
Via Benzinga
Cutera, Inc. Announces Fourth Quarter and Full-Year 2021 Financial Results Along With 2022 Outlook
From Cutera, Inc.
Via Business Wire
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2021 Results on February 22, 2022
From Cutera, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.